Who's Running Pfizer's Neurontin Antitrust Defense? Judge Says Company, Counsel "Inverted" Their Roles
This article was originally published in The Pink Sheet Daily
Executive Summary
A magistrate judge says Pfizer has failed to find a witness who knows the basis for the company's denial of off-label marketing of the anti-epileptic; direct purchasers granted class certification.